Trial Profile
A single center cohort study to evaluate the renal outcomes in lung transplant patients switched to Everolimus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Heart-lung transplant rejection; Lung transplant rejection
- Focus Therapeutic Use
- 09 Nov 2016 New trial record